5. Neugebauer P, Mickenhagen A, Siefer O,
Walger M. A new approach to pharmacological `effect`s on ciliary beat
frequency
in cell cultures--exemplary measurements under Pelargonium sidoides extract (EPs 7630).
Phytomedicine. 2005;12(1−2):46−51.
6. Conrad A. et al. "Extract of Pelargonium
sidoides (EPs® 7630) inhibits the interactions of group A streptococci and host
epithelia in vitro".Phytomedicine 2007; 14: 18−26.
7. Bachert C, Schapowal A, Funk
P, et al. Treatment of acute rhinosinusitis with the preparation from Pelargonium
sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology, 47:
51−58, 2009.
8. Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium
sidoides in children with acute non-group A beta-hemolytic streptococcus
tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther
Health Med. 2003;9(5):68−79.
9. Kamin W, Maydannik V, Malek FA, Kieser M. Efficacy and tolerability of EPS 7630 in
children and adolescents with acute bronchitis. A randomised, double-blind,
placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium
sidoides roots. Int J Clin PharmacolTher 2010a;48:184−91.
10. Kamin W, Maydannik VG, Malek FA, Kieser M. Efficacy and tolerability of EPS 7630 in
patients (aged 6−18 years old) with acute bronchitis. Arandomised, double-blind,
placebo-controlled clinical dose-finding study. Acta Pædiatrica 2010b;99:537−43.
11. Kamin W, Funk P, Seifert G, Zimmermann A, Lehmacher W. EPs
7630 is effective and safe in children under 6 years with acute respiratory tract
infections: clinical studies revisited. Current Medical Research and Opinion, 2018, 34:3,
475−485, DOI: 10.1080/3 007 995.2017.1 402 754.
12. Kamin W, Ilyenko L, Malek F, Kieser M. Treatment of acute bronchitis with EPs 7630:
randomized, controlled trial in children and adol- escents. Pediatrics International
2012;54:219−26.
13. Kayser O, Kolodziej H, Kiderlen AF. Immunomodulatory Principles of Pelargonium sidoides.
Phytother Res 2001;15:122−6.
14. Kolodziej H, Kayser O, Gutmann M. Arzneilich verwendete Pelargonien aus Südafrika. Dtsch
Apoth Ztg 1995;135:853−64.
15. Kolodziej H, Kayser O. Pelargonium sidoides DC. — Neueste
Erkenntnisse zum Verständnis des Phytotherapeutikums Umckaloabo. Z Phytother
1998;19:141−51.
16. Kolodziej H, Schulz V. Umckaloabo — Von der traditionellen
Anwendung zum modernen Phytotherapeutikum. Dtsch Apoth Ztg 2003b;143:1303−12.
17. Loew D und Koch E. Differenzierte Risikobetrachtung mit dem Beispiel eines pflanzlichen
Arzneimittels. Z Phytotherapie 2008;29:28−36.
18. Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of
Pelargonium sidoides (Eps 7630) in adults with acute broncitis. A randomised, double-blind,
placebo-controlled trial. Phytomedicine 2003;10 (Suppl.IV):7−17.
19. Matthys Hand Heger M. EPs 7630-solution- an effective therapeutic option in acute and
exacerbating bronchitis. Phytomedicine 2007a;14(Suppl VI):65−8.
20. Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides (EPs 7630) in the treatment of
acute bronchitis in adults and children. Phytomedicine 2007b;14(SupplVI):69−73.
21. Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation
from Pelargonium sidoides (EPS 7630): a randomised, double-blind, placebo-controlled,
multicentre study. Current Medical Research & Opinion 2007c;23:323−31.
22. Matthys H, Lizogub VG, Malek FA, Kieser M. Efficacy and tolerability of EPS 7630 tablets
in patients with acute bronchitis: a randomised, double-blind, placebo-controlled
dose-finding study with a herbal drug preparation from Pelargonium sidoides. Current Medical
Research & Opinion 2010a;26:1413−22.
23. Matthys H, Lizogub VG, Funk P, Malek FA. Pelargonium sidoides bei akuter Bronchitis —
Gesundheitsbezogene Lebensqualität und Therapiebeurteilung aus Patientensicht unter
Behandlung mit EPs 7630. Wien Med Wochenschr 2010b;160/21−22:564−70.
24. Matthys H, Pliskevich DA, Bondarchuk OM, Malek FA, Tribanek M, Kieser M. Randomised,
double-blind, placebo-controlled trial od EPS 7630 in adults with COPD. Respiratory Medicine
2013;107:691−701.
25. Perić A, Gaćeša D, Barać A, Sotirović J, Perić AV. Herbal Drug EPs 7630 versus
Amoxicillin
in Patients with Uncomplicated Acute Bacterial Rhinosinusitis: A Randomized,
Open-Label Study. Ann Otol Rhinol Laryngol. 2020 Oct;129(10):969−976. doi:
10.1177/3 489 420 918 266. Epub 2020 May 26. PMID: 32 456 442.
26. Perić A, Vezmar Kovačević S, Barać A, Gaćeša D, Perić AV, Vojvodić D. Effects of
Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with
non-purulent acute rhinosinusitis. J Drug Assess. 2020;9(1):145−150. Published 2020 Nov 4.
27. Riley DS, Lizogub VG, Heger M, Funk P,
Mueller H, Lehmacher W. Treatment with EPs 7630, a Pelargonium Sidoides Root Extract,
Is Effective and Safe in Patients with the Common Cold: Results From a Randomized,
Double Blind, Placebo-Controlled Clinical Trial. Integr Med (Encinitas).
2019;18(1):42−51.
28. Schapowal A, Heger M. EPs 7630 Lösung (Umckaloabo®) bei Sinusitis. Z Phytother
2007;28:58−65.
29. Tahan Fand Yaman M. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma
attacks during viral infections of the upper respiratory tract in children?
Phytomedicine 2013;20:148−50.
30. Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides
extract for treating acute respiratory tract infections (Review). Cochrane Database for
Systematic Reviews 2013, Issue 10.
31. Литусов Н.В. Общая микробиология. Иллюстрированное учебное пособие. Екатеринбург: Изд-во
УГМУ, 2015. — 516 с.